BK ablation attenuates osteoblast bone formation via integrin pathway.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
30 09 2019
Historique:
received: 04 06 2019
accepted: 05 09 2019
revised: 04 09 2019
entrez: 2 10 2019
pubmed: 2 10 2019
medline: 22 8 2020
Statut: epublish

Résumé

Impaired bone formation is one of the major causes of low bone mass and skeletal fragility that occurs in osteoporosis. However, the mechanisms underlying the defects in bone formation are not well understood. Here, we report that big conductance calcium-activated potassium channels (BKs) are required for bone formation and osteoblast function both in vivo and in vitro. By 15 weeks of age, BK knockout (BKO) mice exhibited a decline in bone mineral density and trabecular bone volume of the tibiae and lumbar vertebrae, which were associated with impaired bone formation and osteoblast activity. Mechanistically, BK ablation in bone and bone marrow mesenchymal stem cells (BMSCs) of BKO mice inhibited integrin signaling. Furthermore, the binding of α subunit of BK with integrin β1 protein in osteoblasts was confirmed, and FAK-ERK1/2 signaling was proved to be involved by genetic modification of KCNMA1 (which encodes the α subunit of BK) in ROS17/2.8 osteoblast cells. These findings indicated that BK regulates bone formation by promoting osteoblast differentiation via integrin pathway, which provided novel insight into ion transporter crosstalk with the extracellular matrix in osteoblast regulation and revealed a new potential strategy for intervention in correcting bone formation defects.

Identifiants

pubmed: 31570694
doi: 10.1038/s41419-019-1972-8
pii: 10.1038/s41419-019-1972-8
pmc: PMC6769012
doi:

Substances chimiques

Integrins 0
Kcnma1 protein, mouse 0
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits 0
Potassium Channels, Calcium-Activated 0
Focal Adhesion Kinase 1 EC 2.7.10.2
Ptk2 protein, mouse EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

738

Subventions

Organisme : British Heart Foundation
ID : FS/16/5/32054
Pays : United Kingdom

Références

Physiol Rev. 2017 Jan;97(1):39-87
pubmed: 27807200
FASEB J. 2017 Mar;31(3):937-953
pubmed: 27881487
J Biol Chem. 2010 Nov 19;285(47):36410-9
pubmed: 20851880
Physiol Rep. 2017 Jul;5(14):
pubmed: 28754781
J Biol Chem. 2011 Sep 9;286(36):31064-71
pubmed: 21757754
J Membr Biol. 1993 Jan;131(1):81-92
pubmed: 8433353
J Cell Physiol. 2016 Mar;231(3):587-96
pubmed: 26206105
J Cell Biochem. 2011 Mar;112(3):750-5
pubmed: 21328448
Stem Cells. 2005 Mar;23(3):371-82
pubmed: 15749932
Sci Rep. 2016 Feb 11;6:20875
pubmed: 26863924
Chem Biol Drug Des. 2014 Jan;83(1):1-26
pubmed: 24119115
J Membr Biol. 1984;80(1):49-58
pubmed: 6434742
Physiology (Bethesda). 2016 May;31(3):233-45
pubmed: 27053737
J Membr Biol. 2000 Nov 1;178(1):11-20
pubmed: 11058683
Mol Cells. 2016 Jul;39(7):530-5
pubmed: 27329042
J Biol Chem. 2012 Jun 22;287(26):21741-50
pubmed: 22556415
J Cell Biol. 2011 Jul 25;194(2):307-22
pubmed: 21768292
JAMA. 2017 Jan 17;317(3):253-254
pubmed: 27942715
Am J Physiol Cell Physiol. 2009 Dec;297(6):C1397-408
pubmed: 19776394
J Bone Miner Res. 1997 Dec;12(12):1984-92
pubmed: 9421231
J Gen Physiol. 2017 Apr 3;149(4):431-441
pubmed: 28246116
Curr Pharm Des. 2003;9(32):2677-85
pubmed: 14529540
Calcif Tissue Int. 2008 Sep;83(3):222-9
pubmed: 18787886
Endocr Rev. 2010 Jun;31(3):266-300
pubmed: 20051526
Trends Endocrinol Metab. 2014 Nov;25(11):567-75
pubmed: 25034128
Calcif Tissue Int. 2010 May;86(5):404-10
pubmed: 20354682
J Bone Miner Res. 2012 Mar;27(3):538-51
pubmed: 22072425
J Bone Miner Res. 2016 Dec;31(12):2227-2238
pubmed: 27391080
Pharmacol Res. 2015 Nov;101:56-64
pubmed: 26305431
PLoS One. 2011;6(6):e21168
pubmed: 21695131
Nat Rev Mol Cell Biol. 2011 Dec 22;13(1):27-38
pubmed: 22189423
J Cell Physiol. 2017 Sep;232(9):2427-2435
pubmed: 27514023
Endocrinology. 2007 Jun;148(6):2613-21
pubmed: 17332067
J Bone Miner Res. 2002 Apr;17(4):603-11
pubmed: 11918217
Expert Opin Ther Targets. 2011 Nov;15(11):1283-95
pubmed: 21923633
Cell Mol Life Sci. 2015 Oct;72(19):3677-93
pubmed: 26070303
J Cell Physiol. 2014 Feb;229(2):202-12
pubmed: 23881642
Int Immunopharmacol. 2014 Oct;22(2):427-43
pubmed: 25027630
J Bone Miner Res. 2010 Jul;25(7):1468-86
pubmed: 20533309
Calcif Tissue Int. 2005 Jan;76(1):39-49
pubmed: 15477996
J Bone Miner Res. 2014 Jun;29(6):1311-21
pubmed: 24496911
Protein Cell. 2012 Dec;3(12):883-92
pubmed: 22996175
J Endocrinol. 2011 May;209(2):139-51
pubmed: 21307119
J Membr Biol. 1996 Mar;150(2):175-84
pubmed: 8661778
J Physiol. 2004 Feb 1;554(Pt 3):659-72
pubmed: 14578475
J Biol Chem. 2000 Aug 18;275(33):25556-61
pubmed: 10840032
J Bone Miner Res. 2002 May;17(5):869-78
pubmed: 12009018
FEBS Lett. 2003 Nov 27;555(1):62-5
pubmed: 14630320
J Bone Miner Res. 2003 Oct;18(10):1863-71
pubmed: 14584897
J Bone Miner Res. 1990 Dec;5(12):1201-10
pubmed: 2075833

Auteurs

Yinhang Wang (Y)

Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China.

Qiang Guo (Q)

Department of Bone Metabolism, Institute of Radiation Medicine, Fudan University, Shanghai, 200032, China.

Hongya Hei (H)

Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China.

Jie Tao (J)

Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.

Yi Zhou (Y)

Department of Bone Metabolism, Institute of Radiation Medicine, Fudan University, Shanghai, 200032, China.

Jibin Dong (J)

Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China.

Hong Xin (H)

Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China.

Hui Cai (H)

Department of Medicine, Renal Division, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Section of Nephrology, Atlanta Veteran Administration Medical Center, Decatur, GA, 30033, USA.

Jianjun Gao (J)

Department of Bone Metabolism, Institute of Radiation Medicine, Fudan University, Shanghai, 200032, China.

Ker Yu (K)

Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China.

Svetlana Reilly (S)

Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

Peihao Yin (P)

Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China.

Xuemei Zhang (X)

Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, 201203, China. xuemzhang@fudan.edu.cn.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH